Indoco receives EIR for its Plant I manufacturing facility in Goa
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
The appointment is effective from May 01, 2023 for five years
CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology
Bridging the gap between histopathology and molecular pathology
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
Showcased digital innovations: MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients
Subscribe To Our Newsletter & Stay Updated